KDSTEM
/ EHL Bio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2024
Safety and Efficacy of KDSTEM Inj. in Patients With Chronic Kidney Disease
(clinicaltrials.gov)
- P1 | N=6 | Recruiting | Sponsor: EHL Bio Co., Ltd. | Not yet recruiting ➔ Recruiting | Initiation date: Nov 2023 ➔ Feb 2024
Enrollment open • Trial initiation date • Chronic Kidney Disease • Nephrology • Renal Disease
1 to 1
Of
1
Go to page
1